NSRGY News and Press, Nestle SA ADR Reg Shs Ser B From 10/13/20

Société des Produits Nestlé S.A. ((SPN)), a Nestle (NSRGY) subsidiary announces the results of the tender offer, to purchase all of the outstanding shares of Aimmune Therapeutics' (AIMT) common stock for $34.50/share. The offer expired on October 9. Equinity Trust Company,...

30 dividend stocks, down from 40 at the end of Q2. New scoring system includes Piotroski F-Score and Altman Z-Score. Moving toward a less hands-on approach. 30 stocks ranked for relative dividend strength. For further details see: Q3 2020 Portfolio Review

Are These The Best Beverage Stocks To Buy [Or Avoid] Right Now? Beverage stocks have been largely affected by the coronavirus pandemic just like the food sector. Numerous beverage companies depended on restaurant sales to stay afloat to an extent. Top restaurant stocks h...

Palm Beach, FL – September 29, 2020 – Over 85% of American adults snack between dinner and bed.  They combine to consume over $50 billion annually in nighttime snacks.  The most popular nighttime snacks are all loaded with excess calories from fat or sugar (or both)....

Beverage companies are challenging some of the results from a Consumer Reports article that pointed to toxic PFAS chemicals in several popular water brands. Coca-Cola's (KO) Topo Chico said it would continue to make improvements to prepare for more stringent standards in the future, while Nes...

Quick Take Laird Superfood ( LSF ) has filed to raise $41.8 million in an IPO of its common stock, according to an S-1 registration statement . The firm sells plant-based natural foods and related products to consumers. LSF looks to be well positioned to sell its products to younger dem...

Nestle ( OTCPK:NSRGY ) subsidiary Société des Produits Nestlé S.A. (SPN) is commencing today a cash tender offer to purchase all of the outstanding common shares of Aimmune Therapeutics (NASDAQ: AIMT ) for $34.50/share. More news on: Nestlé S.A., Aimmune Ther...

Nestle ( OTCPK:NSRGY ) made some news today at a fireside chat that was part of the virtual version of the Barclays Global Consumer Staples Conference. More news on: Nestlé S.A., Nestlé S.A., Consumer stocks news, Merger & acquisition news, Read more ...

Investment Thesis Earlier this year, Aimmune Therapeutics, Inc. ( AIMT ) unveiled Palforzia, the first and only FDA approved therapy to suppress the effects of peanut allergy. The lockdown measures hindered its market launch, and the company failed to realize sales to arrest the stock&#...

Shares of the peanut allergy drugmaker Aimmune Therapeutics (NASDAQ: AIMT) jumped by a jaw-dropping 159% during August, according to data provided by S&P Global Market Intelligence . The biopharma's shares took flight last month after the announcement of a $2.6 billion merger agreement...